235B Animal Science/Veterinary Medicine Building
1988 Fitch Avenue
University of Minnesota
St. Paul, MN 55108
DVM, Veterinary Medicine, Yangzhou University, China
Ph.D, Molecular, Cellular, & Developmental Biology, Iowa State University, Ames, Iowa
Postdoctoral, Immunology, Cornell University Medical Center, New York, New York
Postdoctoral, Immunology, University of Alabama at Birmingham, Birmingham, Alabama
Main research interest is in immunogenetics of human inflammatory diseases. Specifically, Dr. Wu’s lab is investigating the roles of immune-related gene polymorphisms in the pathogenesis of chronic human inflammatory diseases (lupus, rheumatoid arthritis, and cardiovascular diseases). In addition, Dr. Wu is also studying the genetics of human neutrophil antigens involving in transfusion related diseases.
(For a comprehensive list of Dr. Wu's recent publications, refer to PubMed, a service provided by the National Library of Medicine.)
Wang Y, Wu J, Newton R, Bahaie NS, Long C, Walchek B. ADAM17 cleaves CD16b (FcgRIIIb) in human neutrophils. Biochim Biophys Acta. 2012 Dec 8;1833(3):680-685. doi: 10.1016/j.bbamcr.2012.11.027.
Gibson AW, Li X, Wu J, Baskin JG, Raman, C, Edberg JC, and Kimberly RP. Serine phosphorylation of FcgRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G. J. Leukocyte Biol. 2012; 91:97-103.
Shrestha S, Wiener H, Shendre A, Kaslow RA, Wu J, Edberg JC, and Portman MA. Role of activating FcgR gene polymorphisms in Kawasaki Disease susceptibility and IVIG treatment response. Circulation: Cardiovascular Genetics. 2012; 5:309-316.
Wang CM, Ho HH, Chang SW, Wu YJ, Lin JC, Chang PY, Wu J, and Chen JY. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther. 2012; 14:R125, 1-10.
Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, and Kimberly RP. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci USA. 2011;108:20736-20741.
Wu J, Xie F, Qian K, Gibson AW, Edberg JC, Kimberly RP. Fas mRNA editing in human systemic lupus erythematosus. Human Mutation. 2011, 32:1268-1277.
Wu J, Richards MH, Huang J, Al-Harthi L, Xu X, Lin R, Xie F, Gibson AW, Edberg JC, and Kimberly RP. Human FasL gene is a target of B-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. PLoS One. 2011; 6(10):e26143. doi:10.1371/journal.pone.0026143.
Chen JY, Lin CY, Wang CM, Lin YT, Kuo SN, Shiu CF, Chang SW, Wu J, and Sheen IS. IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-a plus ribavirin therapy in Taiwanese chronic HCV infection. Genes Immun. 2011;12:300-309.
Chen JY, Wang CM, Wu YJ, Kuo SN, Shiu CF, Chang SW, Lin YT, Ho HH, Ma CC, Hsu LA, and Wu J. Disease phenotypes and gender association of FCRL3 SNP - 169T/C in Taiwanese. J. Rheumatol. 2011;38:264-270.
Gibson AW, Li FJ, Wu J, Edberg JC, Su K, Cafardi J, Wiener H, Tiwari H, Kimberly RP, Davis RS. The FCRL3 -169CT promoter SNP, which is associated with SLE in a Japanese population, predicts receptor protein expression on CD19+ B cells. Arthritis Rheum. 2009; 60:3510-3512.
Qian K, Xie F, Gibson AW, Edberg JC, Kimberly RP, and Wu J. Functional expression of IgA receptor FcαRI on human platelets. J. Leukocyte Biol. 2008; 84:1492-1500.
Chen JY, Wang CM, Ma CC, Hsu LA, Ho HH, Wu YJ, Kuo SN, and Wu J. A Transmembrane polymorphism in FcγRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA. Genes Immun. 2008; 9:680-688.
Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP. FcaRI (CD89) alleles determine the proinflammatory potential of serum IgA. J. Immunol. 2007; 178:3973-3982.
Li X, Su K, Ji C, Szalai AJ, Wu J, Zhang Y, Zhou T, Kimberly RP, and Edberg JC. Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion. J. Immunol. 2008; 181:1012-1018.
Edberg JC, Wu J, Langefeld CD, Brown EE, Marion MC, McGwin G, Petri M, Ramsey-Goldman R, Reveille JD, Frank SG, Kaufman KM, John B. Harley JB, Alarcón GS, Kimberly RP. Genetic variation in the CRP promoter: association with Systemic Lupus Erythematosus (SLE). Hum Mol Genet. 2008; 17:1147-1155.
Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, and Wu J. Association of transmembrane polymorphism of FcγRIIb (FCGR2B) with systemic lupus erythematosus in Taiwanese. Arthritis Rheum. 2006; 54:3908-3917.
Chen JY, Wang CM, Wu J, Ho H-H, Luo SF. Association of rheumatoid factor production with FcγIIIa polymorphism in Taiwanese rheumatoid arthritis patients. Clin. Exp. Immunol. 2006; 144:10-16.
Sato K, Yang X-L, Yudate T, Chung J-S, Wu J, Luby-Phelps K, Kimberly RP, Underhill D, Ponciano D. Cruz PD. Jr., and Ariizumi K. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ-chain to induce innate immune responses. J. Biol. Chem. 2006; 281:38854-38866
Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, Williams A, Zakharkin SO, George V, Allison DB, Cooper GS, Xie F, Fan Z, Edberg JC, Kimberly RP. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J. Mol. Med. 2005; 83:440-447.
Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS, Langefeld CD, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgRIIb alters receptor expression and associates with autoimmunity. J. Immunol. 2004; 172:7186-7191.
Wu J, Metz C, Xiulong Xu X, Abe R, Gibson AW, Edberg JC, Cooke J, Xie F, Cooper GS, Kimberly RP. A novel polymorphic C/EBPb element in the FasL gene promoter alters FasL expression: a candidate background gene in African American SLE patients. J. Immunol. 2003; 170:132-138.
Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS, Kimberly RP. A novel polymorphism in Fc gamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 2003; 48:3242-3252.
Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 2001; 166:3915-3922.
Li XR, Chong AS, Wu J, Roebuck KA, Kumar A, Parrillo JE, Rapp UR, Kimberly RP, Williams JW, Xu X. Transcriptional regulation of Fas expression by GA binding protein and AP-1 in T cell antigen receptor CD3 complex-stimulated T cells. J. Biol. Chem. 1999; 274:35203-35210.
Wu J, Edberg JC, Gibson AW, Tsao BP, Kimberly RP. Single nucleotide polymorphisms of TCR zeta chain in SLE patients. Arthritis Rheum. 1999; 42:2601-2605.
Wu J, Edberg JC, Redecha PB, Bansal VK, Guyre PM, Coleman K, Salmon JE, Kimberly RP. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 1997; 100:1059-1070.
“Novel neutrophil antigens and transfusion-related diseases”. The goal of the project is to identify and characterize novel human neutrophil antigens involved in transfusion-related diseases.
“Function of FcγRIIC gene in rheumatoid arthritis”. The goal of this project is to characterize the function of human FcγRIIC gene in B cell activation and to investigate whether FcγRIIC polymorphisms are associated with disease risk for rheumatoid arthritis and severity.